Immuron Limited (IMRN)
NASDAQ·Healthcare·Biotechnology
$0.85
-2.40%
Mkt Cap $5.38M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 25, 2026 | $2.89M | $2.97M | +3.06% | -$0.01 | -$0.20 | -2586.23% | — | — |
| Q1 2026 Feb 24, 2026 | $2.89M | $2.74M | -5.04% | -$0.01 | -$0.18 | -2376.38% | — | — |
| Q3 2025 Aug 28, 2025 | $2.00M | $2.16M | +7.85% | -$0.01 | -$0.31 | -2219.50% | — | — |
| Q1 2025 Mar 31, 2025 | — | $985.77K | — | — | -$0.14 | — | — | — |
| Q1 2025 Feb 28, 2025 | $1.67M | $2.47M | +48.32% | -$0.01 | -$0.27 | -1922.73% | — | — |
| Q3 2024 Sep 30, 2024 | — | $1.36M | — | — | -$0.15 | — | — | — |
| Q3 2024 Aug 29, 2024 | — | $1.70M | — | — | -$0.57 | — | — | — |
| Q2 2024 Apr 29, 2024 | — | $1.60M | — | — | -$0.25 | — | — | — |
| Q1 2024 Mar 31, 2024 | — | $826.48K | — | — | -$0.28 | — | — | — |
| Q3 2023 Aug 30, 2023 | — | $405.45K | — | — | -$0.11 | — | — | — |
| Q4 2022 Dec 30, 2022 | — | $199.43K | — | — | -$0.12 | — | — | — |
| Q3 2022 Aug 30, 2022 | — | $367.32K | — | — | -$0.13 | — | — | — |
| Q4 2021 Dec 30, 2021 | — | $167.41K | — | — | -$0.23 | — | — | — |
| Q3 2021 Sep 7, 2021 | — | $94.20K | — | — | -$0.35 | — | — | — |
| Q4 2020 Dec 30, 2020 | — | $15.57K | — | — | -$0.80 | — | — | — |
| Q2 2020 Jun 30, 2020 | — | $666.53K | — | — | -$0.22 | — | — | — |
| Q4 2019 Dec 30, 2019 | $1.13M | $1.09M | -3.49% | — | -$0.24 | — | — | — |
| Q3 2019 Aug 30, 2019 | — | $985.09K | — | — | -$0.58 | — | — | — |
| Q4 2018 Dec 30, 2018 | — | $688.94K | — | — | -$0.33 | — | — | — |
| Q2 2018 Jun 30, 2018 | — | $679.97K | — | — | -$0.24 | — | — | — |